[Septic shock due to primary myonecrosis of psoas].
González Robledo
J
J
Pérez Losada
M E
ME
Ballesteros Herráez
J C
JC
Rodríguez Encinas
A
A
D000437:Alcoholism / Q000150:complications; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D002561:Cerebrovascular Disorders / Q000150:complications; D003023:Cloxacillin / Q000008:administration & dosage / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D004322:Drainage; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D005839:Gentamicins / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009336:Necrosis; D016659:Psoas Abscess / Q000150:complications* / Q000000981:diagnostic imaging / Q000382:microbiology / Q000601:surgery; D012772:Shock, Septic / Q000209:etiology*; D013203:Staphylococcal Infections / Q000150:complications* / Q000188:drug therapy / Q000601:surgery; D014057:Tomography, X-Ray Computed
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D003023:Cloxacillin